Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
24.37
+1.51 (6.61%)
At close: Feb 6, 2026, 4:00 PM EST
22.00
-2.37 (-9.72%)
After-hours: Feb 6, 2026, 5:41 PM EST
Tectonic Therapeutic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
51
Market Cap
456.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2014 | 137.88K | 2.88K | 2.13% |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 212.07M |
| Niagen Bioscience | 124.71M |
| Assembly Biosciences | 37.19M |
| Lineage Cell Therapeutics | 10.82M |
| PureTech Health | 6.39M |
| Absci | 2.82M |
| vTv Therapeutics | 17.00K |
TECX News
- 2 months ago - Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point - Seeking Alpha
- 3 months ago - Tectonic Therapeutic, Inc. (TECX) Discusses Positive Topline Results From Phase Ib Part B Trial of TX45 in PH-HFrEF Patients Transcript - Seeking Alpha
- 3 months ago - Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF - GlobeNewsWire
- 5 months ago - Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewsWire
- 7 months ago - Tectonic Therapeutic Joins Russell 3000® Index - GlobeNewsWire
- 9 months ago - Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025 - GlobeNewsWire
- 9 months ago - Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 10 months ago - Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF - Seeking Alpha